By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

Medical technology company Nyxoah has officially launched its Genio system, a small implant that has the potential to treat obstructive sleep apnea (OSA) without the need for a CPAP machine.

If you can't tolerate a CPAP machine, a medical professional may be able to recommend alternative snoring treatments. If you think you have sleep apnea or ... snorer with no serious underlying ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

Since sleep apnea affects nearly a billion people worldwide, and using a CPAP machine ... offers a promising alternative to current therapies. We reached out to sleep medicine and obesity medicine ...

"Too often, obstructive sleep apnea is brushed off as 'just snoring' - but it's far more than that," said Julie Flygare, CEO ...

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people with OSA don't sleep well, they are at a higher risk for motor vehicle ...

With a HCPCS code and two major distribution agreements in hand, Signifier Medical Technologies is creating a path for itself and sleep stakeholders looking for an alternative to CPAP ...

Sleep apnea affects 25 million Americans and 100 million individuals worldwide. Prior to the approval of Zepbound, those affected have mainly been offered a CPAP machine for treatment, often ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...